×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South Korea Biopsy Devices Market

ID: MRFR/HC/54672-HCR
200 Pages
MRFR Team
June 2025

South Korea Biopsy Devices Market Research Report: By Product Type (Biopsy Guns, Biopsy Guidance System, Biopsy Needles, Biopsy Forceps, Localization Wires, Others), By Application (Breast Biopsy, Prostate Biopsy, Liver Biopsy, Lung Biopsy, Gynecological Biopsy, Others), By Guidance (Ultrasound-Guided Biopsy, Stereotactic Guided Biopsy, MRI-Guided Biopsy, CT Guided Biopsy, Others) andBy End User (Hospitals & Clinics, Diagnostic & Imaging Centers, Academic & Research Institutes, Others)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Options

South Korea Biopsy Devices Market Summary

Industry Developments

The South Korea Biopsy Devices Market has seen significant developments in recent years. In October 2023, Medtronic announced advancements in its biopsy device technology aimed at improving precision and patient outcomes. Additionally, Johnson and Johnson introduced new minimally invasive biopsy techniques that gained traction among healthcare providers. The market presently continues to expand, with a notable increase in demand for advanced diagnostic tools among South Korean hospitals, contributing to an overall market valuation growth attributed to increasing healthcare expenditures and emphasis on early detection of diseases. Furthermore, in June 2023, Abbott Laboratories bolstered its presence in the South Korean market by entering a partnership with local healthcare institutions to enhance the use of its biopsy products. There have been no significant mergers or acquisitions reported for major players like Stryker and Hologic recently. However, press releases indicated ongoing collaborations among various companies as they aim to leverage emerging technologies such as artificial intelligence in biopsy procedures. Overall, the South Korea Biopsy Devices Market is in a dynamic phase of growth due to innovation and cooperative strategies between leading healthcare corporations.

Report Scope

Report Scope:
Report Attribute/Metric Source:Details
MARKET SIZE 201852.8(USD Million)
MARKET SIZE 202456.2(USD Million)
MARKET SIZE 2035110.4(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 6.33% (2025 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
MARKET FORECAST PERIOD2025 - 2035
HISTORICAL DATA2019 - 2024
MARKET FORECAST UNITSUSD Million
KEY COMPANIES PROFILEDMedtronic, Stryker, Abbott Laboratories, Thermo Fisher Scientific, Johnson & Johnson, Hologic, GE Healthcare, Cardinal Health, AngioDynamics, C.R. Bard, Boston Scientific, B. Braun, Siemens Healthineers, Olympus, Cook Medical
SEGMENTS COVEREDProduct Type, Application, Guidance, End User
KEY MARKET OPPORTUNITIESGrowing demand for minimally invasive procedures, Increasing prevalence of cancer cases, Advancements in imaging technologies, Rising healthcare expenditure, Expansion of diagnostics and research facilities
KEY MARKET DYNAMICSRising cancer incidence, Technological advancements, Increasing aging population, Growing healthcare expenditure, Enhanced diagnostic accuracy
COUNTRIES COVEREDSouth Korea

Leave a Comment

FAQs

What is the expected market size of the South Korea Biopsy Devices Market in 2024?

The South Korea Biopsy Devices Market is expected to be valued at 56.2 USD Million in 2024.

What will be the market value of the South Korea Biopsy Devices Market by 2035?

By 2035, the South Korea Biopsy Devices Market is anticipated to reach a value of 110.4 USD Million.

What is the expected compound annual growth rate (CAGR) for the South Korea Biopsy Devices Market from 2025 to 2035?

The market is projected to grow at a CAGR of 6.33% from 2025 to 2035.

Which product type is expected to have the largest market share in 2024?

Biopsy Needles are expected to have the largest market share with a value of 17.5 USD Million in 2024.

What is the projected market size for Biopsy Guns in 2035?

The market size for Biopsy Guns is expected to reach 22.0 USD Million by 2035.

Who are the major players in the South Korea Biopsy Devices Market?

Key players include Medtronic, Stryker, Abbott Laboratories, Thermo Fisher Scientific, and Johnson & Johnson.

What market value does the Biopsy Guidance System hold in 2024?

The Biopsy Guidance System is valued at 9.0 USD Million in 2024.

What is the expected growth rate for the Biopsy Forceps segment from 2025 to 2035?

The Biopsy Forceps segment is projected to experience significant growth, reaching a market value of 20.5 USD Million by 2035.

What challenges does the South Korea Biopsy Devices Market face?

Challenges include regulatory hurdles and the need for technological advancements in biopsy procedures.

Are there any emerging trends in the South Korea Biopsy Devices Market?

Emerging trends include increased usage of minimally invasive techniques and advancements in imaging guidance systems.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions